Hepatitis E Virus
- 1 September 1999
- journal article
- Published by S. Karger AG in Intervirology
- Vol. 42 (2-3) , 179-184
- https://doi.org/10.1159/000024978
Abstract
Hepatitis E, previously known as enterically transmitted, enteric, or epidemic hepatitis, is a worldwide public health problem. The causative agent, the hepatitis E virus, is involved in epidemic, sporadic, and fulminant hepatitis cases worldwide. This review describes the advances in the biology of the hepatitis E virus and the progress made to develop simple and robust serologic assays for the diagnosis of HEV infection. Genomic sequence comparisons with a recently identified US isolate now suggests three genetic groups of HEV viruses. A highly conserved animal isolate found in pigs suggest the coexistence of animal and human isolates of HEV. The use of recombinant technology to develop an effective subunit vaccine capable of providing cross-protection for the most divergent HEV strains has been established and is reviewed.Keywords
This publication has 5 references indexed in Scilit:
- Recombinant vaccine against hepatitis E: dose response and protection against heterologous challengeVaccine, 1997
- A novel virus in swine is closely related to the human hepatitis E virusProceedings of the National Academy of Sciences, 1997
- The sequence of hepatitis E virus isolated directly from a single source during an outbreak in ChinaVirus Research, 1993
- Molecular cloning and sequencing of the mexico isolate of hepatitis E virus (HEV)Virology, 1992
- Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genomeVirology, 1991